日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1

靶向OTUB2的药物可通过降解PD-L1使肿瘤对细胞毒性T细胞更加敏感。

Wenfeng Ren # ,Zilong Xu # ,Yating Chang # ,Fei Ju # ,Hongning Wu # ,Zhiqi Liang # ,Min Zhao ,Naizhen Wang ,Yanhua Lin ,Chenhang Xu ,Shengming Chen ,Yipeng Rao ,Chaolong Lin ,Jianxin Yang ,Pingguo Liu ,Jun Zhang ,Chenghao Huang ,Ningshao Xia

A potent neutralizing and protective antibody against a conserved continuous epitope on HSV glycoprotein D

针对 HSV 糖蛋白 D 上保守连续表位的强效中和和保护性抗体

Rui Tian, Fei Ju, Mengqin Yu, Zhiqi Liang, Zilong Xu, Min Zhao, Yaning Qin, Yanhua Lin, Xiaoxuan Huang, Yating Chang, Shaopeng Li, Wenfeng Ren, Chaolong Lin, Ningshao Xia, Chenghao Huang

Intratumoral Delivery of a PD-1-Blocking scFv Encoded in Oncolytic HSV-1 Promotes Antitumor Immunity and Synergizes with TIGIT Blockade

肿瘤内递送溶瘤 HSV-1 编码的 PD-1 阻断 scFv 可促进抗肿瘤免疫并与 TIGIT 阻断产生协同作用

Chaolong Lin #, Wenfeng Ren #, Yong Luo, Shaopeng Li, Yating Chang, Lu Li, Dan Xiong, Xiaoxuan Huang, Zilong Xu, Zeng Yu, Yingbin Wang, Jun Zhang, Chenghao Huang, Ningshao Xia

Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens

靶向肿瘤的溶瘤病毒可引发针对肿瘤抗原的强效免疫治疗疫苗反应

Yong Luo, Chaolong Lin, Yidi Zou, Fei Ju, Wenfeng Ren, Yanhua Lin, Yale Wang, Xiaoxuan Huang, Huiling Liu, Zeng Yu, Pingguo Liu, Guowei Tan, Quan Yuan, Jun Zhang, Chenghao Huang, Ningshao Xia

A novel approach for rapid high-throughput selection of recombinant functional rat monoclonal antibodies

一种快速高通量筛选重组功能性大鼠单克隆抗体的新方法

Qin Chen ,Shengping Qiu ,Huanhuan Li ,Chaolong Lin ,Yong Luo ,Wenfeng Ren ,Yidi Zou ,Yale Wang ,Ninghshao Xia ,Chenghao Huang